<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Funch | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/teethjoseph6/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/teethjoseph6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Funch.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b86f2c9163f4a7d03fee352a1d7cf282</guid>
				<title>Funch posted an update: Intermediate care describes services, including transitional [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42263/</link>
				<pubDate>Sun, 09 Feb 2025 08:39:15 -0800</pubDate>

									<content:encoded><![CDATA[<p>Intermediate care describes services, including transitional care, that support the needs of middle-aged and older adults during care transitions and between different settings. This scoping review aimed to examine the effectiveness of intermediate care including transitional care interventions for middle-aged and older adults on function,&hellip;<span class="activity-read-more" id="activity-read-more-42263"><a href="http://www.nationalboardinstitute.com/activity/p/42263/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d2f57e3f5986b544e3e7d09e3a224625</guid>
				<title>Funch posted an update: 6 and ≤24.9 %, respectively, which are below the speci [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41435/</link>
				<pubDate>Sat, 08 Feb 2025 08:55:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>6 and ≤24.9 %, respectively, which are below the species demarcation thresholds. Based on the results of phenotypic, phylogenetic and genomic analyses, strain G-4-1-14T represents a novel species in the genus Zoogloea, for which the name Zoogloea dura sp. nov. is proposed. The type strain is G-4-1-14T (=KACC 21618T=NBRC 114358T). In addit&hellip;<span class="activity-read-more" id="activity-read-more-41435"><a href="http://www.nationalboardinstitute.com/activity/p/41435/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b51ee2a09c7366a3428498c24e20e4e0</guid>
				<title>Funch posted an update: Among the morphea patients, those with sleeping problems [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39597/</link>
				<pubDate>Thu, 06 Feb 2025 09:05:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>Among the morphea patients, those with sleeping problems during COVID-19 had a significantly higher mean HADS-D score (</p>
<p> =.048). Notably, 21.43% of patients discontinued their treatment due to fear of COVID-19 and experienced disease recurrence. Adherence to health protocols was higher in patients compared with controls. The rate of COVID-19&hellip;<span class="activity-read-more" id="activity-read-more-39597"><a href="http://www.nationalboardinstitute.com/activity/p/39597/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3a3566389b63528851f4f4cf33c06d5a</guid>
				<title>Funch posted an update: 001), an FM system (OR 3.84 vs. BIBR1532 No-TT, p  less t [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37027/</link>
				<pubDate>Mon, 03 Feb 2025 08:45:51 -0800</pubDate>

									<content:encoded><![CDATA[<p>001), an FM system (OR 3.84 vs. <a href="https://www.selleckchem.com/products/BIBR1532.html" rel="nofollow ugc">BIBR1532</a> No-TT, p  less then  0.001; OR 15.13 vs. Control, p  less then  0.001), and an implanted bone conduction device (OR 5.08 vs. No-TT, p  less then  0.001; OR 15.67 vs. Control, p  less then  0.001). CONCLUSIONS An association between ear tube placement and long-term need for a rehabilitative hearing device&hellip;<span class="activity-read-more" id="activity-read-more-37027"><a href="http://www.nationalboardinstitute.com/activity/p/37027/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3e3bd616fc0fcafc5b32768c16002821</guid>
				<title>Funch posted an update: Wantai SARS-COV-2 Ab ELISA, Elecsys Anti-SARS-CoV-2 assay, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35276/</link>
				<pubDate>Sat, 01 Feb 2025 08:52:37 -0800</pubDate>

									<content:encoded><![CDATA[<p>Wantai SARS-COV-2 Ab ELISA, Elecsys Anti-SARS-CoV-2 assay, and Innovita 2019-nCoV Ab rapid test showed least cross-reactivity, resulting in an optimal analytical specificity greater than 98%.</p>
<p> Wantai SARS-COV-2 Ab ELISA and Elecsys Anti-SARS-CoV-2 assays are suitable for sensitive and specific detection of SARS-CoV-2 antibodies from 10 days&hellip;<span class="activity-read-more" id="activity-read-more-35276"><a href="http://www.nationalboardinstitute.com/activity/p/35276/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6a0f314cdce7dff772030b8e2a57cf59</guid>
				<title>Funch posted an update: The women reported consuming an average of 53% of their [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34453/</link>
				<pubDate>Fri, 31 Jan 2025 08:55:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>The women reported consuming an average of 53% of their total food from what they cultivated or raised. Women with higher DD [MMD-W score ≥ 5 food groups (79% of total sample)] were on farms that cultivated a greater variety of crops (x = 8.7 vs. 6.7), raised more animals (x = 17.9 vs. 12.7, p less then 0.05), and reported lower HFI and s&hellip;<span class="activity-read-more" id="activity-read-more-34453"><a href="http://www.nationalboardinstitute.com/activity/p/34453/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">92ad78bc9876b0af84e62b7a3b5eeb4e</guid>
				<title>Funch posted an update: Each section for knowledge, attitude, and practice were [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32907/</link>
				<pubDate>Wed, 29 Jan 2025 09:03:36 -0800</pubDate>

									<content:encoded><![CDATA[<p>Each section for knowledge, attitude, and practice were categorized as poor (≤39.0%), fair (40.0-69.0%), and good (≥70.0%). The level of knowledge of OAC therapy for patients with NVAF among PCPs was insufficient in over half (75.8%) of the participants. The majority (89.8%) of PCPs had a positive attitude and 68.0% had modest performance in the&hellip;<span class="activity-read-more" id="activity-read-more-32907"><a href="http://www.nationalboardinstitute.com/activity/p/32907/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9133a89c758b1737d849594a4b55fdae</guid>
				<title>Funch posted an update: Mast cell-derived IL-13 was required for induction of AAMΦ, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27716/</link>
				<pubDate>Tue, 28 Jan 2025 09:59:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>Mast cell-derived IL-13 was required for induction of AAMΦ, whereas mast cell-derived IL-6 enhanced macrophage responsiveness to IL-13 via upregulation of the IL-4Rα receptor. Furthermore, we found that AAMΦ polarized by IL-33-stimulated mast cells could suppress proliferation and IL-17 and IFN-γ production by T cells. Finally, we show that AAM&hellip;<span class="activity-read-more" id="activity-read-more-27716"><a href="http://www.nationalboardinstitute.com/activity/p/27716/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b66f52cd6353447e7e0323c50506f332</guid>
				<title>Funch became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27674/</link>
				<pubDate>Tue, 28 Jan 2025 09:52:35 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>